Aliskiren/amlodipine/hydrochlorothiazide
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Project Osprey (talk | contribs) at 13:31, 15 February 2016 (Adding CAS No). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
| Combination of | |
|---|---|
| Aliskiren | Renin inhibitor |
| Amlodipine | Calcium channel blocker |
| Hydrochlorothiazide | Diuretic |
| Clinical data | |
| AHFS/Drugs.com | Consumer Drug Information |
| License data | |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| (verify) | |
The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved by the U.S. Food and Drug Administration (FDA) on December 21, 2010.[1]
References
External links
| ACE inhibitors ("-pril") |
|
|---|---|
| AIIRAs ("-sartan") | |
| Renin inhibitors ("-kiren") | |
| Dual ACE/NEP inhibitors | |
| Neprilysin inhibitors | |
| |
| Sulfonamides (and etacrynic acid) |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Potassium-sparing (at CD) |
| ||||||||
| Osmotic diuretics (PT, DL) | |||||||||
| Vasopressin receptor inhibitors (DCT and CD) | |||||||||
| Other | |||||||||
| Combination products | |||||||||
| |||||||||
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |